scholarly journals A familial case of pseudohypoaldosteronism type II (PHA2) with a novel mutation (D564N) in the acidic motif in WNK4

2019 ◽  
Vol 7 (6) ◽  
Author(s):  
Takashi Sakoh ◽  
Akinari Sekine ◽  
Takayasu Mori ◽  
Hiroki Mizuno ◽  
Masahiro Kawada ◽  
...  
Hypertension ◽  
2005 ◽  
Vol 46 (2) ◽  
pp. 295-300 ◽  
Author(s):  
Amir P. Golbang ◽  
Meena Murthy ◽  
Abbas Hamad ◽  
Che-Hsiung Liu ◽  
Georgina Cope ◽  
...  

FEBS Open Bio ◽  
2018 ◽  
Vol 8 (3) ◽  
pp. 461-469 ◽  
Author(s):  
Leping Shao ◽  
Li Cui ◽  
Jingru Lu ◽  
Yanhua Lang ◽  
Irene Bottillo ◽  
...  

Nephrology ◽  
2020 ◽  
Vol 25 (11) ◽  
pp. 818-821
Author(s):  
Kiyoshi Nakano ◽  
Yasuo Kubota ◽  
Takayuki Mori ◽  
Motoko Chiga ◽  
Takayasu Mori ◽  
...  

Endocrine ◽  
2008 ◽  
Vol 33 (3) ◽  
pp. 230-234 ◽  
Author(s):  
Hui Gong ◽  
Zhengyi Tang ◽  
Yang Yang ◽  
Lihao Sun ◽  
Wei Zhang ◽  
...  

2000 ◽  
Vol 67 (2) ◽  
pp. 302-310 ◽  
Author(s):  
Sandra Disse-Nicodème ◽  
Jean-Michel Achard ◽  
Isabelle Desitter ◽  
Anne-Marie Houot ◽  
Albert Fournier ◽  
...  

2013 ◽  
Vol 28 (9) ◽  
pp. 1881-1884 ◽  
Author(s):  
Madori Osawa ◽  
Yumi Ogura ◽  
Kiyoshi Isobe ◽  
Shinichi Uchida ◽  
Shigeaki Nonoyama ◽  
...  

Author(s):  
Markus Braun-Falco ◽  
Henry J. Mankin ◽  
Sharon L. Wenger ◽  
Markus Braun-Falco ◽  
Stephan DiSean Kendall ◽  
...  

2018 ◽  
Vol 94 (3) ◽  
pp. 514-523 ◽  
Author(s):  
Karen I. López-Cayuqueo ◽  
Maria Chavez-Canales ◽  
Alexia Pillot ◽  
Pascal Houillier ◽  
Maximilien Jayat ◽  
...  

Biology Open ◽  
2015 ◽  
Vol 4 (11) ◽  
pp. 1509-1517 ◽  
Author(s):  
Y. Araki ◽  
T. Rai ◽  
E. Sohara ◽  
T. Mori ◽  
Y. Inoue ◽  
...  

2017 ◽  
Vol 37 (7) ◽  
Author(s):  
Emi Sasaki ◽  
Koichiro Susa ◽  
Takayasu Mori ◽  
Kiyoshi Isobe ◽  
Yuya Araki ◽  
...  

ABSTRACT Mutations in the with-no-lysine kinase 1 (WNK1), WNK4, kelch-like 3 (KLHL3), and cullin3 (CUL3) genes are known to cause the hereditary disease pseudohypoaldosteronism type II (PHAII). It was recently demonstrated that this results from the defective degradation of WNK1 and WNK4 by the KLHL3/CUL3 ubiquitin ligase complex. However, the other physiological in vivo roles of KLHL3 remain unclear. Therefore, here we generated KLHL3 −/− mice that expressed β-galactosidase (β-Gal) under the control of the endogenous KLHL3 promoter. Immunoblots of β-Gal and LacZ staining revealed that KLHL3 was expressed in some organs, such as brain. However, the expression levels of WNK kinases were not increased in any of these organs other than the kidney, where WNK1 and WNK4 increased in KLHL3−/− mice but not in KLHL3+/− mice. KLHL3−/− mice also showed PHAII-like phenotypes, whereas KLHL3+/− mice did not. This clearly demonstrates that the heterozygous deletion of KLHL3 was not sufficient to cause PHAII, indicating that autosomal dominant type PHAII is caused by the dominant negative effect of mutant KLHL3. We further demonstrated that the dimerization of KLHL3 can explain this dominant negative effect. These findings could help us to further understand the physiological roles of KLHL3 and the pathophysiology of PHAII caused by mutant KLHL3.


Sign in / Sign up

Export Citation Format

Share Document